key: cord-1043054-bw72kpji
authors: Zarifian, Ahmadreza; Nour, Mohammad Ghasemi; Rezayat, Arash Akhavan; Oskooei, Reza Rahimzadeh; Abbasi, Bita; Sadeghi, Ramin
title: Chest CT sfindings of coronavirus disease 2019 (COVID-19): A comprehensive meta-analysis of 9907 confirmed patients
date: 2020-10-25
journal: Clin Imaging
DOI: 10.1016/j.clinimag.2020.10.035
sha: 21ef4744b8fecbbfad344fe362953faa602ee041
doc_id: 1043054
cord_uid: bw72kpji

OBJECTIVES: We performed a systematic review and meta-analysis of the prevalence of chest CT findings in patients with confirmed COVID-19 infection.Methods: Systematic review of the literature was performed using PubMed, Scopus, Embase, and Google Scholar to retrieve original studies on chest CT findings of patients with confirmed COVID-19, available up to 10 May 2020. Data on prevalence and distribution of chest CT findings were extracted from eligible studies, pooled and meta-analyzed using random-effects model to calculate prevalence data of chest CT findings. RESULTS: Overall, 103 studies (pooled population: 9907 confirmed COVID-19 patients) were meta-analyzed. Most common CT findings were ground-glass opacities (GGOs) (77.18%, 95%CI = 72.23–81.47), reticulations (46.24%, 95%CI = 38.51–54.14), and air bronchogram (41.61%, 95%CI = 32.78–51.01). Pleural thickening (33.35%, 95%CI = 21.89–47.18) and bronchial wall thickening (15.48%, 95%CI = 8.54–26.43) were major atypical and airway findings. Findings were predominantly distributed bilaterally (75.72%, 95%CI = 70.79–80.06) and peripherally (65.64%, 95%CI = 58.21–72.36), while 8.20% (95%CI = 6.30–10.61) of patients had no abnormal findings and pre-existing lung diseases were present in 6.01% (95%CI = 4.37–8.23). CONCLUSIONS: The most common CT findings in COVID-19 are GGOs with/without consolidation, reticulations, and air bronchogram, which mostly involved both lungs with peripheral distribution. However, COVID-19 might present with atypical manifestations or no abnormal findings in chest CT, which deserve clinicians' notice.

Since the outbreak of coronavirus disease 2019 (COVID-19) -primarily known as 2019 novel coronavirus or 2019-nCoV -in December 2019, a global effort has been undertaken to make timely diagnosis and prevention of the disease possible. On the 30 th of January 2020, the world health organization announced COVID-19 as a global health emergency (1) . As of April 25, 2020, COVID-19 has infected over five million patients with more than 342,000 confirmed deaths worldwide, and the WHO has characterized the situation as a pandemic (2, 3) . infection, rapid spread of the disease mandates the healthcare system to look for a faster, easier, and more available diagnostic tool. With the growing body of evidence on COVID-19 infection, chest CT is establishing its role in early diagnosis of the disease. Chest CT is now considered as an integral part in evaluation of suspected COVID-19 patients as a reliable, quick, and practical method for detection and assessment of COVID-19, particularly in the epidemic areas. Recent studies have shown superior sensitivity of CT scan in comparison with RT-PCR method for diagnosis of COVID-19 (4, 5) .

The typical chest CT finding of COVID-19 infection is reported to be multiple bilateral groundglass opacities (GGOs) with a predominantly peripheral distribution. Although these imaging studies have used nonstandard (non-Fleischner society terms) for describing lung abnormalities, which are included in the previous meta-analyses and have made the reported estimates somewhat inaccurate. In March 2020, a consensus statement of reporting CT findings was published by the Radiologic Society of North America (RSNA), which categorized the CT findings into typical and atypical (9) . This categorization was based on the frequency of findings reported in the literature published by the time. Since then, some reports indicated the frequency of atypical findings to be higher than what was previously thought. Herein, we systematically reviewed the available literature on the chest CT findings in patients with confirmed molecular diagnosis of COVID-19 infection, and evaluated the frequency of typical and atypical findings in a large sample size of over 9900 patients.

A computerized search was conducted to identify and to screen studies available online up to ("COVID-19" OR "coronavirus disease 2019" OR "2019 novel coronavirus" OR "2019-nCoV" OR "coronavirus" OR "SARS-CoV-2" OR "SARS 2") AND ("Computed tomography" OR "computerized tomography" OR "chest computed" OR "chest computerized" OR "chest CT" OR "CT scan" OR "CT imaging") J o u r n a l P r e -p r o o f

All published studies in English language with an abstract or a full-text version containing any of the search terms relevant to our review were retrieved from the searched databases for further evaluation. Moreover, after selection of the eligible studies for inclusion in the review, their reference lists were manually checked for any possible missing relevant article.

All studies containing data on chest CT findings of 10 or more patients with confirmed diagnosis of COVID-19 using RT-PCR were included in our study. We excluded articles of the following types: review, editorial, letter to editor, and reply to authors, unless they provided data on chest CT findings of 10 or more patients with confirmed COVID-19. Studies without sufficient information or those with no quantitative report of the frequency for chest CT findings were also excluded from the systematic review.

Moreover, studies that used nonstandard terminology for description of all their chest CT findings (those not compliant with Fleischner society standards for thoracic imaging (10)) were excluded. However, for studies in which only some of the reported findings were nonstandard, we only included the standard terminology in that study.

Two investigators (A.Z. and M.G.N.) independently reviewed the titles and abstracts of all obtained studies for eligibility screening. After excluding the duplicates and irrelevant studies, all remaining studies underwent full-text review. If two studies were performed on similar patients from a single hospital with mutual authors and adjacent publication dates, the study with smaller sample size was excluded to reduce the chance of duplicate data. In order to reduce the risk of bias and duplicate data, only studies reporting chest CT findings on 10 or more patients were included in our meta-analysis.

Four investigators (A.Z., A.A.R., M.G.N., and R.R.O.) read the included full text articles to extract the study characteristics, demographic information, and chest CT findings. Extracted study characteristics were publication/acceptance date, first author, report origin (city and country from which the work originated), study design, and sample size. Extracted demographics of the patients included sex and age.

The frequency of each chest CT finding that was reported using standard terminology in patients with positive RT-PCR for COVID-19 was also extracted. Findings of the chest CT were organized according to the standard terminology for thoracic imaging provided by the Fleischner society (10) . Accordingly, in an attempt to standardize the terminology we organized the reticular patterns including interlobular septal thickening and crazy paving in one single finding named "reticulation with/without GGO". We also included nonspecific linear opacities (i.e. linear opacities, fibrotic stripes or streaks, and subpleural lines) and reverse halo sign in one single finding named "organizing pneumonia patterns". We incorporated all pre-existing lung diseases reported by the studies, including chronic obstructive pulmonary disease, tuberculosis, bronchiectasis, malignancies, and asthma into one group of findings named "pre-existing lung diseases". Besides, all chest CT patterns representing chronic lung diseases (e.g. usual interstitial pneumonia in idiopathic pulmonary fibrosis, and other interstitial lung diseases) were also included in this group as a single finding named "pulmonary fibrosis". We categorized the findings into typical and atypical in an attempt to be in accordance with the Radiological Society of North America Expert consensus statement on reporting chest CT findings related to COVID-19 (11) . Typical findings included GGO with/without consolidation, reticulation with/without GGO, round GGO/consolidation, air bronchogram, consolidation, organizing pneumonia patterns, and halo sign. Atypical findings included pleural thickening, pulmonary nodules, pleural effusion, lymphadenopathy, pneumothorax, and cavitation.

Bronchial wall thickening and airway secretions (mucoid impaction) were included in central bronchial findings category.

The frequency of normal CT (no findings) was also recorded for each study. Furthermore, the distribution of findings in terms of the involved lungs, respective lobes, and the dispersion of the lesions in the lung field were extracted.

All studies included in the meta-analysis underwent quality assessment. Quality appraisal of case series studies was performed using the institute of health economics (IHE) checklist and the critical appraisal tool to assess the quality of cross-sectional studies (AXIS) was used to assess the quality of the included cross-sectional studies (12, 13) . In order to avoid score discrepancy between investigators, a single investigator (M.G.N.) evaluated all the included articles and scored them on a scale of 0-20.

The IHE quality appraisal tool for the evaluation of case series studies originally includes 20 items assessing the methodologic quality of case series studies to generate a score of 0 to 20. It provides an effective means to assess the quality of non-controlled studies, which constitute a major part of our study. In cases without repeated measurements, the study was awarded the J o u r n a l P r e -p r o o f Journal Pre-proof scores for questions 11, 13 and 14, which are specific to studies with a repeated-measures design (13). The AXIS is also a 20-item checklist developed for critical appraisal of the cross-sectional studies, scoring the quality of studies on a scale of 0 to 20 (12) .

In an attempt to minimize the publication bias, we searched several databases and search engines. We also included grey literature and preprints in the systematic review. Moreover, we assessed publication bias using the trim and fill method, Egger's test, and funnel plots.

The prevalence data were pooled across included studies using a random effects model. Data were summarized as frequency and 95% confidence interval (95%CI). Moreover, we assessed heterogeneity of the findings and provided its indicators including the I-squared (I 2 ) index.

All analyses were performed using comprehensive meta-analysis software, version 3.3.070 (Biostat, Englewood). We followed the preferred reporting items for systematic reviews and meta-analyses (PRISMA) checklist. Table 2 shows the distribution of chest CT findings in COVID-19 patients.

Funnel plots regarding the publication bias for two major findings (GGOs and normal chest CT) are shown in Figures 3 and 4 . The results of Egger's test as well as trim and fill method for quantitative assessment of publication bias regarding several major findings of our study are illustrated in Table 3 .

This systematic review and meta-analysis was designed to analyze the reported chest CT findings in patients with COVID-19 pneumonia. Although chest radiograph is the first-line imaging modality in most patients with acute respiratory syndrome, lung CT is suggested as the subsequent study or even the imaging modality of choice in selected situations (117, 118) . In spite of its relatively low specificity, chest CT has been reported to be a highly sensitive and halo sign (25.63%). Bronchial wall thickening was also the most common airway finding in the patients (15.48%). Other relatively uncommon atypical findings were nodules (13.11%), pleura effusion (6.96%), lymphadenopathy (5.19%), cavitation (1.1%), and pneumothorax (0.89%). Overall, airway secretion (mucoid impaction) was the rarest chest CT finding, with a prevalence of 0.83%. Pleural thickening, generally categorized as an uncommon finding, had a prevalence of 33.35%, which is much more than the generally expected rate. We found the prevalence of pre-existing respiratory diseases to be around 6% in the patients with confirmed COVID-19 diagnosis, as reported in a large body of reviewed studies. This relatively low prevalence implies that the majority of reported abnormal chest CT findings in the patients can be mainly imputed to COVID-19 and not to the pre-existing conditions. However, as most of the included patients were symptomatic and of older age, some of the reported findings might inevitably be due to the aging-related respiratory conditions that were not accurately reported by the studies. This can be the reason why some atypical findings were found to be prevalent in our J o u r n a l P r e -p r o o f Journal Pre-proof study. For instance, the relatively high prevalence for pleural thickening, which is considered an atypical finding for COVID-19, can be because it is a non-specific finding and can be present in a variety of abnormal respiratory conditions. A study evaluating the incidence of new pleural thickening in patients with multiple CT studies could be helpful in clarifying this topic.

Relatively similar results were reported by a recent meta-analysis of 4121 patients with COVID-19. Zhu et al. reported the most common findings to be GGO (68.1%), air bronchogram (44.7%), crazy-paving pattern (35.6%), and consolidation (32.0%), respectively. They found pleural thickening to be present in 27.1%, while lymphadenopathy and pleural effusion were present in 5.4% and 5.3% of patients, respectively (122) .

The typical findings in chest CT scans of patients with confirmed COVID-19 were generally comparable to those found in patients with other viral pneumonias, mainly severe acute respiratory syndrome and Middle East respiratory syndrome (21, 98, 123, 124) . However, atypical and uncommon presentations on chest CT are also reported by some studies. Therefore, clinicians, particularly radiologists, should be aware of the uncommon findings as well, especially in cases with pulmonary comorbidities such as lung cancer (125) (126) (127) (128) (129) .

Our meta-analysis showed an approximate 91.8% rate of abnormal CT manifestations, indicating an 8.2% rate of normal CT. This is in line with the 8.4% prevalence of normal chest CT in a recent meta-analysis (122) . Inconsistently, a recent meta-analysis of eight studies on COVID-19 patients, which is not published yet (preprint) reported a higher rate of 95.6% for incidence of abnormal chest CT findings (130) . Another published meta-analysis of 10 studies also reported a higher rate (96.6%) of abnormal chest CT findings in COVID-19 patients (131) . This inconsistency might be because the mentioned studies included fewer studies that were published early at the beginning of the outbreak, since focusing mainly on the critically symptomatic J o u r n a l P r e -p r o o f patients, which are more likely to present abnormal chest CT findings. Besides, it can be due to the different times of performing CT scan in different studies. As reported in several studies, patients with initially normal chest CT scans in the first days of the disease can develop pulmonary lesions in the following days (36, 132) .

On the one hand, it is worth mentioning that although some patients with COVID-19 might not demonstrate abnormal findings in their initial chest CT studies during the first days of infection, they would probably develop pulmonary opacities in later stages. Therefore, it is recommended that the clinicians follow the patients, since normal chest CT does not unequivocally rule out COVID-19 (36) . On the other hand, initial RT-PCR testing might yield negative results in some patients who have presented with typical chest CT findings and clinical manifestations that raise the suspicion of COVID-19. Since repeated RT-PCR results might also be negative until the late stages of the disease, chest CT can be particularly helpful in such patients, in that it enables the clinicians to detect highly probable COVID-19 patients and take precautionary measures to isolate them and control the spread of the disease (126, 133, 134) . In patients who show negative specimen test, the clinicians should consider the possibility of false-negative results. Therefore, it can be recommended to use a combination of CT scans and RT-PCR tests in patients with initially negative RT-PCR screening but high clinical suspicion of COVID-19 infection (5, 135) .

Early diagnosis of COVID-19 cases enables healthcare professionals to offer adequate clinical monitoring and necessary interventions for the patients, as well as taking precautionary actions to control the spread and prevent further transmission of the infection (136) (137) (138) (139) .

Regarding the assessment of publication bias, funnel plots showed asymmetry and the results of Egger's test confirmed the existence of publication bias for some of our findings. Although publication bias has inevitably affected our findings, quantified assessment using trim and fill J o u r n a l P r e -p r o o f method showed that it did not have a significant effect on the estimated prevalence of our findings, except for lymphadenopathy, which is an atypical finding.

The results of this study can provide useful insights into the CT findings of patients diagnosed with COVID-19 pneumonia. This can be helpful particularly for clinicians who face cases with high clinical suspicion of COVID-19 infection who still lack a confirmed molecular diagnosis or in areas where routine RT-PCR testing is not available. Early diagnosis of COVID-19 cases enables healthcare professionals to offer adequate clinical monitoring and necessary interventions for the patients, as well as taking precautionary actions to control the spread and prevent further transmission of the infection (136) (137) (138) (139) .

This study also has several limitations. For instance, there are still a limited number of studies available from outside China. In order to provide a more comprehensive understanding of chest CT findings of COVID19, more studies from other parts of the world are required. Another limitation of our study is that although we incorporated reported respiratory comorbidities into our analyses, there is still an inevitable possibility that some findings might be related to chronic underlying conditions other than COVID-19, particularly because the disease severity tends to be higher in the older population who carry a higher rate of comorbidities. Possible selection bias in the included studies can also be a limitation, for it is quite likely that most of the imaged patients were selected from those with the worst clinical conditions. Besides, although we tried to minimize the duplicates by excluding small studies and those reporting similar patients from the same hospital in a limited period, our study inevitably carries a risk of including duplicate cases 

Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)

WHO. Rolling updates on coronavirus disease (COVID-19) 2020

Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)

Chest Imaging Appearance of COVID-19 Infection

COVID-19 infection presenting with CT halo sign

Imaging profile of the COVID-19 infection: radiologic findings and literature review

Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA

Fleischner Society: Glossary of Terms for Thoracic Imaging

Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. Radiology: Cardiothoracic Imaging

Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)

Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv

Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital

Analysis of 2019 Novel Coronavirus Infection and Clinical Characteristics of Outpatients: An Epidemiological Study from the Fever Clinic in Wuhan

Predictors for imaging progression on chest CT from coronavirus disease 2019 (COVID-19) patients

Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia

High-resolution Chest CT Features and Clinical Characteristics of Patients Infected with COVID-19 in Jiangsu, China

Clinical characteristics of 225 patients with COVID-19 in a tertiary Hospital near Wuhan

Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT

The clinical course and its correlated immune status in COVID-19 pneumonia

Clinical Features of Patients Infected with the 2019 Novel Coronavirus (COVID-19

Diabetes is a risk factor for the progression and prognosis of COVID-19

Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha

Chest CT Features of COVID-19 in

Imaging characteristics of initial chest computed tomography and clinical manifestations of patients with COVID-19 pneumonia

Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city

Early Prediction of Disease Progression

Novel Coronavirus Pneumonia Patients Outside Wuhan with CT and Clinical Characteristics. medRxiv

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan

Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province

Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis

CT imaging changes of corona virus disease 2019(COVID-19): a multi-center study in Southwest China

Clinical features and laboratory inspection of novel coronavirus pneumonia (COVID-19) in Xiangyang

Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection

CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients from Wuhan city

CT scans of patients with 2019 novel coronavirus (covid-19) pneumonia

Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area

Chest CT findings of COVID-19 pneumonia by duration of symptoms

Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

High-resolution computed tomography manifestations of COVID-19 infections in patients of different ages

CT characteristics of patients infected with 2019 novel coronavirus: association with clinical type

Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multicentre case series

COVID-19) Pneumonia: Early Stage Chest CT Imaging Features and Clinical Relevance. The Lancet Infectious diseases

Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study

Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2

Patients with COVID-19 Pneumonia: A Longitudinal Study. Available at SSRN 3546091

The Clinical and Chest CT Features Associated with Severe and Critical COVID-19 Pneumonia

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. The Lancet Infectious diseases

Chest CT Findings in Patients with Corona Virus Disease 2019 and its Relationship with Clinical Features. Invest Radiol

Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study

The characteristics and clinical value of chest CT images of novel coronavirus pneumonia

CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19)

CT manifestations of coronavirus disease-2019: A retrospective analysis of 73 cases by disease severity

Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China

Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series

CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan

Coronavirus disease 2019: initial chest CT findings

Clinical and CT Imaging Features of the COVID-19 Pneumonia: Focus on Pregnant Women and Children

CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan

COVID-19 pneumonia manifestations at the admission on chest ultrasound, radiographs, and CT: single-center study and comprehensive radiologic literature review

Risk-adapted Treatment Strategy For

Early chest computed tomography to diagnose COVID-19 from suspected patients: A multicenter retrospective study. The American journal of emergency medicine

Imaging Features of Coronavirus disease 2019 (COVID-19): Evaluation on Thin-Section CT

Novel Coronavirus (2019-nCoV) Pneumonia

Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR

Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing, China. medRxiv

COVID-19): Role of Chest CT in Diagnosis and Management

Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19

The performance of chest CT in evaluating the clinical severity of COVID-19 pneumonia: identifying critical cases based on CT characteristics

Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2

Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?

Analysis on the Clinical Characteristics of 36 Cases of Novel Coronavirus Pneumonia in Kunming. medRxiv

Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection

Initial clinical features of suspected Coronavirus Disease 2019 in two emergency departments outside of Hubei

Coronavirus Disease-19 Among Children Outside Wuhan

Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Annals of oncology : official journal of the European Society for Medical Oncology

Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19

Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan

A retrospective study of the clinical characteristics of COVID-19 infection in 26 children

Epidemiological and clinical characteristics of 26 asymptomatic SARS-CoV-2 carriers. The Journal of infectious diseases

Clinical Characteristics of Children with Coronavirus Disease

Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Science China Life sciences

Clinical and Dynamic Computed Tomography Features of 24 Patients With Coronavirus Disease

Novel Coronavirus (2019-nCoV)

Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia. Radiology

Imaging Profile of the COVID-19 Infection: Radiologic Findings and Literature Review

Key Points of Clinical and CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV) Imported Pneumonia Based On 21 Cases Analysis. Available at SSRN 3543610

Clinical and Autoimmune Characteristics of Severe and Critical Cases with COVID-19. Clinical and translational science

Effective treatment of severe COVID-19 patients with tocilizumab

Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. Pediatric pulmonology

Comparison of Epidemiological and Clinical Features of Patients with Coronavirus Disease (COVID-19) in Wuhan and Outside Wuhan

A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias

Novel Coronavirus Pneumonia

Progression Course in 17 Discharged Patients: Comparison of Clinical and Thin-Section CT Features During Recovery

Hospitalized Patients with 2019 Novel Coronavirus Infections Outside Wuhan, China. medRxiv

Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus

Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: a case series of 17 patients

Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study

Epidemiological and clinical features of asymptomatic patients with SARS-CoV-2 infection

Clinical and CT imaging features of 2019 novel coronavirus disease (COVID-19)

Clinical and computed tomographic (CT) images characteristics in the patients with COVID-19 infection: What should radiologists need to know?

Clinical Hallmarks of 13 COVID-19 Patients Revealing SAA Biomarker. Available at SSRN 3546066

Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019

The clinical and immunological features of pediatric COVID-19 patients in China

Presentation of pulmonary infection on ct in covid-19: Initial experience in brazil

COVID-19) in a Single-Center Study in

Clinical characteristics of a case series of children with coronavirus disease 2019. Pediatric pulmonology

Epidemiological and initial clinical characteristics of patients with family aggregation of COVID-19

SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection

Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau

Proposal of a lowdose, long-pitch, dual-source chest CT protocol on third-generation dual-source CT using a tin filter for spectral shaping at 100 kVp for CoronaVirus Disease 2019 (COVID-19) patients: a feasibility study

ACR Appropriateness Criteria(R) Acute Respiratory Illness in Immunocompetent Patients

ACR Appropriateness Criteria(R) Routine Chest Radiography

ACR Recommendations for the use of Chest Radiography and Computed Tomography (CT) for Suspected COVID-19 Infection

COVID-19): A Perspective from China

ACR Recommendations for the use of Chest Radiography and Computed Tomography (CT) for Suspected COVID-19 Infection

CT imaging features of 4121 patients with COVID-19: A meta-analysis

Diagnosis of SARS-CoV-2 Infection based on CT scan vs. RT-PCR: Reflecting on Experience from MERS-CoV. The Journal of hospital infection. 2020

Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome

2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation

Clinical Features of Atypical 2019 Novel Coronavirus Pneumonia with an initially Negative RT-PCR Assay

First Atypical case of 2019 novel coronavirus in Yan'an, China

Atypical lung feature on chest CT in a lung adenocarcinoma cancer patient infected with COVID-19. Annals of oncology : official journal of the European Society for Medical Oncology

Image of pulmonary and diagnosis of atypical novel coronavirus (2019-nCoV) infected pneumonia: case series of 14 patients

Clinical Characteristics of 5732 Patients with 2019-nCoV Infection

Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis

Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study

Use of chest CT in combination with negative RT-PCR assay for the 2019 novel coronavirus but high clinical suspicion

Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing

A Novel Coronavirus from Patients with Pneumonia in China

First Case of 2019 Novel Coronavirus in the United States

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures

Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts